May 29, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Clinicians should carefully monitor patients with inflammatory bowel disease and comorbid Clostridioides difficile infection, co-managing the conditions for better outcomes, according to an AGA clinical practice update. C . difficile infection is more common, severe and likely to recur in patients with IBD than the general population, the authors noted. It
May 29, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Health coaching app helpful for inflammatory bowel disease management

IBD and Mental Health: 'The More We Look at This, the Crazier It Gets'

GLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI Bleeding

Five Things to Know About Weight-Loss Drugs and IBD

Evidence suggests inflammatory bowel disease is equally prevalent in transgender and cisgender populations. However, it remains…

The risk for major adverse cardiovascular events appeared similar between older patients treated with 5-aminosalicylic acid and…

Several nonantibiotic drugs appear associated with increased risk for Clostridioides difficile infection, according to results of…

Integrating a mobile app with online health coaching into usual care boosts outcomes for inflammatory bowel disease (IBD),…

LAS VEGAS — LGBTQ+ individuals with inflammatory bowel disease experience multiple gaps and inequities in care when managing…

The HLA-DRB1*01:03 allele was associated with severe outcomes across inflammatory bowel disease subtypes, including perianal…